Publications

My research interests lie in developing novel, preclinical immunotherapies for glioblastoma (GBM) and translating these therapies for the clinic. Much of my research has been focused on developing next generation chimeric antigen receptor (CAR) T cell therapies to treat brain tumors. I am deeply interested in how therapies like CARs can be leveraged to combat the highly immunosuppressive tumor microenvironment. Additionally, CARs can also be used to resolve the issue of heterogeneity in solid tumors. Heterogeneity remains a roadblock to successful treatment of GBM, but I believe my research can shine some light on potential solutions.

Updated: 2021 April 14